Safir Anand spots a mid-sized company with the right chemistry and catalytic circumstances
Valiant Organics has a strong product portfolio built on healthy financials, and capable promoters with skin in the game
Safir Anand - May 07, 2021
Will private sector bank valuations correct further?
With uncertainty over the magnitude of bad loans due to the moratorium, banks may face a rude shock in the coming months
July 30, 2020
Its IPO was overhyped but is it time to relook at SBI Cards?
Listing amidst a pandemic hurt its market cap, but analysts feel the SBI subsidiary could bounce back in FY22
Anishaa Kumar - July 02, 2020
With attractive valuation and robust financials, Quess Corp seems like a perfect opportunity for investors to latch on to
Prathamesh Mulye - January 08, 2019
Paper.vc provides hard-to-find financials and insights on companies
Debangana Ghosh - July 17, 2018
What's wrong with Rolta?
The mid-sized IT firm will find it tough to resurrect investor confidence as its financials are questioned
Jash Kriplani - May 04, 2015